Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck An Eastern Cooperative Oncology Group Trial (PA390)

Final Report ◽

Oncology Group ◽

Phase Ib Trial of the Effect of Peritumoral and Intranodal Injections of Interleukin-2 in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck: An Eastern Cooperative Oncology Group Trial

Journal of Immunotherapy ◽

10.1097/00002371-199402000-00007 ◽

1994 ◽

Vol 15 (2) ◽

pp. 134-139 ◽

Cited By ~ 22

Author(s):

Daniel R. Vlock ◽

Carl H. Snyderman ◽

Jonas T. Johnson ◽

Eugene N. Myers ◽

David E. Eibling ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Interleukin 2 ◽

Oncology Group ◽

Phase Ib ◽

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Phase II Evaluation of Combined Cisplatin and Vindesine in Advanced Squamous Cell Carcinoma of the Esophagus: Japanese Esophageal Oncology Group Trial

Japanese Journal of Clinical Oncology ◽

10.1093/oxfordjournals.jjco.a039457 ◽

1991 ◽

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Oncology Group ◽

Carcinoma Of The Esophagus ◽

Phase II Evaluation of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: A Japanese Esophageal Oncology Group Trial

Japanese Journal of Clinical Oncology ◽

10.1093/oxfordjournals.jjco.a039543 ◽

1992 ◽

Cited By ~ 1

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Oncology Group ◽

Carcinoma Of The Esophagus ◽

Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): A Trial of the Eastern Cooperative Oncology Group

Cancer Investigation ◽

10.1081/cnv-200039628 ◽

2004 ◽

Vol 22 (6) ◽

pp. 823-831 ◽

Cited By ~ 13

Author(s):

Corey J. Langer ◽

Yi Li ◽

Timothy Jennings ◽

Ronald C. DeConti ◽

Suresh Nair ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma

Oncology Group ◽

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck

Cancer ◽

10.1002/(sici)1097-0142(19980601)82:11<2270::aid-cncr24>3.0.co;2-q ◽

1998 ◽

Vol 82 (11) ◽

pp. 2270-2274 ◽

Cited By ~ 142

Author(s):

Arlene A. Forastiere ◽

Darleen Shank ◽

Donna Neuberg ◽

Samuel G. Taylor ◽

Ronald C. DeConti ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Final Report ◽

Advanced Squamous Cell Carcinoma

Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-0051 ◽

2014 ◽

Vol 20 (19) ◽

pp. 5041-5051 ◽

Cited By ~ 24

Author(s):

Ann Marie Egloff ◽

Ju-Whei Lee ◽

Corey J. Langer ◽

Harry Quon ◽

Alec Vaezi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Head ◽

Oncology Group ◽

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618

Investigational New Drugs ◽

10.1007/s10637-009-9348-z ◽

2009 ◽

Vol 29 (2) ◽

pp. 352-359 ◽

Cited By ~ 18

Author(s):

Susanne M. Arnold ◽

James Moon ◽

Stephen K. Williamson ◽

James N. Atkins ◽

Sai-Hong I. Ou ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Oncology Group ◽

Eribulin Mesylate ◽

Southwest Oncology Group ◽

Recurrent Squamous Cell Carcinoma ◽

Faculty Opinions recommendation of Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3359960.3049058 ◽

2010 ◽

Author(s):

David Potter

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Prospective Trial ◽

Advanced Squamous Cell Carcinoma

393TiP A phase II trial of nedaplatin, 5-fluorouracil and docetaxel for induction chemotherapy with local advanced squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1016/s0923-7534(21)00551-2 ◽

2016 ◽

Vol 27 ◽

pp. ix121-ix122

Author(s):

S. Ueda ◽

D. Nishikawa ◽

K. Yane ◽

Y. Akashi ◽

T. Sakiyama ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Local Advanced